By Cory Doctorow (GPG 0xBF3D9110957E5F4C) @doctorow.pluralistic.net · 06/10/2026Sure, a pharma exec like Martin Shkreli or Arthur Sackler can command the production and sale of a molecule whose method of action isn't known but whose therapeutic value has been demonstrated. 1191
By Cory Doctorow (GPG 0xBF3D9110957E5F4C) @doctorow.pluralistic.net · 06/10/2026But to improve on that molecule, they must pay research scientists to study and unravel the method of action. Replace those experts with theory-free inference, and finance can emerge triumphant in the only forum in which it is routinely vanquished. 1271
By Cory Doctorow (GPG 0xBF3D9110957E5F4C) @doctorow.pluralistic.net · 06/10/2026This is the political economy of theory-free AI. Without finance's infinite hostility to expertise, there would have been far less capital for theory-free AI. 1326
